A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: A magnetic resonance imaging study

American Heart Journal

Volumn 163, Issue 3, 2012, Pages 500-507

  Song, Young Bin ^a   Hahn, Joo Yong ^a   Gwon, Hyeon Cheol ^a   Chang, Sung A ^a,b   Lee, Sang Chol ^a,b   Choe, Yeon Hyeon ^b   Choi, Seung Hyuk ^a   Choi, Jin Ho ^a   Lee, Sang Hoon ^a   Oh, Jae K ^b  

^a Division of Cardiology   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HEART INFARCTION SIZE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84863360689     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.12.007     Document Type: Article

References (21)

1. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
2. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
3. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
4. T. Cuisset, C. Frere, and J. Quilici Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting J Am Coll Cardiol 48 2006 1339 1345
5. G. Montalescot, G. Sideris, and C. Meuleman A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial J Am Coll Cardiol 48 2006 931 938
6. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability Eur Heart J 25 2004 1903 1910
7. S.R. Mehta, J.F. Tanguay, and J.W. Eikelboom Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
8. G. Dangas, R. Mehran, and G. Guagliumi Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol 54 2009 1438 1446
9. J.Y. Hahn, H.C. Gwon, and Y.H. Choe Effects of balloon-based distal protection during primary percutaneous coronary intervention on early and late infarct size and left ventricular remodeling: a pilot study using serial contrast-enhanced magnetic resonance imaging Am Heart J 153 2007 665.e1 665.e8
10. H.Y. Lee, J.H. Kim, and B.O. Kim Effect of aspiration thrombectomy on microvascular dysfunction in ST-segment elevation myocardial infarction with an elevated neutrophil count Korean Circ J 41 2011 68 75
11. A.W. van 't Hof, A. Liem, and H. Suryapranata Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
12. J. Ganame, G. Messalli, and S. Dymarkowski Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction Eur Heart J 30 2009 1440 1449
13. I. Eitel, S. Desch, and G. Fuernau Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction J Am Coll Cardiol 55 2010 2470 2479
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. G.B. Kim, J.K. Kim, and S. Park Effect of atorvastatin and clopidogrel co-administration after coronary stenting in korean patients with stable angina Korean Circ J 41 2011 28 33
16. P.J. Sharis, C.P. Cannon, and J. Loscalzo The antiplatelet effects of ticlopidine and clopidogrel Ann Intern Med 129 1998 394 405
17. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
18. H. Thiele, M.J. Kappl, and S. Conradi Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging J Am Coll Cardiol 47 2006 1641 1645
19. R.J. Kim, D.S. Fieno, and T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
20. A.M. Beek, H.P. Kuhl, and O. Bondarenko Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction J Am Coll Cardiol 42 2003 895 901
21. H. Mahrholdt, A. Wagner, and T.A. Holly Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging Circulation 106 2002 2322 2327